US Stock MarketDetailed Quotes

IMNN Imunon

Watchlist
  • 1.170
  • +0.045+4.00%
Close Apr 19 16:00 ET
  • 1.190
  • +0.020+1.71%
Post 16:48 ET
11.00MMarket Cap-541P/E (TTM)

About Imunon Company

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Company Profile

SymbolIMNN
Company NameImunon
Listing DateFeb 8, 2008
Founded1982
CEOMr. Michael H. Tardugno
MarketNASDAQ
Employees33
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address997 Lenox Drive,Suite 100
CityLawrenceville
ProvinceNew Jersey
CountryUnited States of America
Zip Code08648
Phone1-609-896-9100
Websitehttp://imunon.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael H. Tardugno
  • Executive Chairman of the Board and Chief Executive Officer
  • 1.43M
  • Dr. Sebastien Hazard, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Jeffrey W. Church
  • Executive Vice President and Chief Financial Officer
  • 679.92K
  • Dr. Khursheed Anwer, M.B.A.,PhD
  • Executive Vice President and Chief Scientific Officer
  • 680.16K
  • Kimberly A. Graper
  • Vice President of Finance and Controller
  • --
  • Frederick J. Fritz
  • Independent Director
  • 106.20K
  • James E. Dentzer
  • Independent Director
  • 61.20K
  • Dr. Stacy R. Lindborg
  • Independent Director
  • 44.10K
  • Dr. Donald Braun, PhD
  • Independent Director
  • 72.90K
  • Christine A. Pellizzari
  • Independent Director
  • 47.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg